patheon  global pharma contract development  manufacturing cdmo  a healthier world delivered play video careers investors connect solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers connect ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts close solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers connect ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts menu menu solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers connect ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts flexible biomanufacturing reduce your risks instead of your return learn more about our flexible biomanufacturing capabilities news  june  patheon to invest  million expanding capabilities to support continued growt connect connect with patheon today biomanufacturing for consultants reduce your clients’ risks instead of their return checkout our consultants’ guide to flexible biomanufacturing solutions event  august    august  the summer symposium on process chemistry news  june  patheon reports fiscal  second quarter flexible manufacturing customized solutions adaptable capacity welcome to truly flexible drug manufacturing events  august    august  the bioprocesssing summit company profile discover how patheon has the innovation and expertise to transform the pharma industry ask the experts  our scientific experts are here to answer your inquiries submit your question here events  august    august  american drug delivery  formulation summit news  may  thermo fisher scientific to acquire patheon a leading contract development and  formulation learn more about the solid and sterile dose forms available at patheon solubility solutions welcome to getting solubility right the first time see our solubility enhancement solutions linkedin social media twitter patheon onesource see how patheon onesource™ accelerates every step of drug development  and more importantly eliminates the spaces between them patheon at a glance download our company overview pdf looking for solutions we can help connect with us solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval  post approval life cycle management about us company profile investor relations our history leadership sites quality our clients our commitments faqs news  press events careers working at patheon job opportunities connect for clients for investors for media members for job seekers ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts   patheon®terms of use privacy statement patheonjp patheon  wikipedia patheon from wikipedia the free encyclopedia jump to navigation search patheon nv type public company traded as nyse pthn industry contract pharmaceutical services headquarters amsterdam the netherlands key people james c mullen ceo stuart grant cfo and executive vp revenue  billion  number of employees  website wwwpatheoncom patheon nv is a pharmaceutical contract development and manufacturing organization cdmo headquartered in amsterdam it provides contract development and manufacturing services of prescription and overthecounter pharmaceutical products for approximately  pharmaceutical and biotechnology companies it was founded in  as custom pharmaceuticals ltd and changed its name to patheon in  when it was first publicly traded the new york private equity firm jll partners has owned a controlling stake in patheon since  in  patheon merged with the drug manufacturing business of royal dsm nv becoming a jointventure between jll partners and dsm as of  patheon owns manufacturing sites in north america europe japan australia and canada contents  history  dosage forms products  references  external links historyedit patheon was founded in canada in  as custom pharmaceuticals ltd in  it began to expand to us markets custom pharmaceuticals changed its name to patheon in  and was first publicly traded that year on the toronto stock exchange in  patheon acquired mova a drug manufacturer based in puerto rico us the deal proved unprofitable and in  the new york equity firm jll partners provided patheon  million to restructure two years later after a failed takeover bid by lonza group jll partners bought a controlling interest in the company in  patheon acquired banner pharmacaps a drug manufacturer specializing in softgels for  million patheon changed the companys name the following year to banner life sciences in a  billion deal patheon merged with the pharmaceutical division of royal dsm nv in  after jll partners bought a controlling stake in the latter as well adding significantly to patheons european production capacity in  patheon acquired agere pharmaceuticals an oregon us company specializing in drug solubility and irix a maker of specialist active pharmaceutical ingredients in south carolina us the latter for  million in may  thermo fisher scientific announced it would acquire patheon for  billion dosage forms productsedit patheon does not own any of the licences of the products it manufactures and is often listed as the manufacturer on packaging with the product licence holders brand name product name and corporate identity being used patheons clients include such pharmaceutical brands as merck  co novartis and sanofi aventis with biotechnology customers including amgen and avanir pharmaceuticals patheon has manufactured or developed more than  products development activities are undertaken by patheon pharmaceutical development services known as pds a division of patheon inc operating in europe canada and the united states as of  patheon owns manufacturing sites in canada the continental us puerto rico france the united kingdom italy austria germany the netherlands japan and australia patheon manufactures products in various dosage forms oral tablets capsules injectable sterile products vials ampoules prefilled syringes containing liquids powders and lyophilisates and topicals creams ointments drops nasal sprays medicated and nonmedicated gauze referencesedit  leadership patheoncom patheon retrieved may     palmer eric june   updated patheon revenues hit b in first year as part of dpx fiercepharmacom fierce pharma retrieved may     a b company profile patheoncom patheon retrieved may     a b history and milestones patheoncom patheon retrieved may     erman boyd july   long takeover battle a bitter pill for patheon theglobeandmailcom the globe and mail retrieved may     xu jodi november   jll forms new pharma firm with dsm in  billion deal bloombergcom bloomberg retrieved may     a b sites patheoncom patheon retrieved may      takeover failures revisited   httpwwwbizjournalscomtriadblogpatheonchangingbannerpharmacapsnamehtml  jll forms new pharma firm with dsm in  billion deal  november  – via wwwbloombergcom   biopharmareportercom patheon propels itself into us biologics market in gallus acquisition   trlpcpatheon to raise  mln euro loan for irix acquisition  march  – via reuters   httpwwwbizjournalscomportlandmorningcalloregonpharmacompanysoldtonorthcarolinahtml  thermo fisher scientific to acquire patheon for b  gen genetic engineering  biotechnology news  biotech from bench to business  gen gen   patheon by the numbers pdf patheoncom patheon retrieved may    external linksedit patheon home page retrieved from httpsenwikipediaorgwindexphptitlepatheonoldid categories companies established in pharmaceutical companies of the netherlandscompanies based in amsterdamcompanies listed on the new york stock exchange initial public offeringshidden categories pages using deprecated image syntax navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view patheon  wikipedia patheon from wikipedia the free encyclopedia jump to navigation search patheon nv type public company traded as nyse pthn industry contract pharmaceutical services headquarters amsterdam the netherlands key people james c mullen ceo stuart grant cfo and executive vp revenue  billion  number of employees  website wwwpatheoncom patheon nv is a pharmaceutical contract development and manufacturing organization cdmo headquartered in amsterdam it provides contract development and manufacturing services of prescription and overthecounter pharmaceutical products for approximately  pharmaceutical and biotechnology companies it was founded in  as custom pharmaceuticals ltd and changed its name to patheon in  when it was first publicly traded the new york private equity firm jll partners has owned a controlling stake in patheon since  in  patheon merged with the drug manufacturing business of royal dsm nv becoming a jointventure between jll partners and dsm as of  patheon owns manufacturing sites in north america europe japan australia and canada contents  history  dosage forms products  references  external links historyedit patheon was founded in canada in  as custom pharmaceuticals ltd in  it began to expand to us markets custom pharmaceuticals changed its name to patheon in  and was first publicly traded that year on the toronto stock exchange in  patheon acquired mova a drug manufacturer based in puerto rico us the deal proved unprofitable and in  the new york equity firm jll partners provided patheon  million to restructure two years later after a failed takeover bid by lonza group jll partners bought a controlling interest in the company in  patheon acquired banner pharmacaps a drug manufacturer specializing in softgels for  million patheon changed the companys name the following year to banner life sciences in a  billion deal patheon merged with the pharmaceutical division of royal dsm nv in  after jll partners bought a controlling stake in the latter as well adding significantly to patheons european production capacity in  patheon acquired agere pharmaceuticals an oregon us company specializing in drug solubility and irix a maker of specialist active pharmaceutical ingredients in south carolina us the latter for  million in may  thermo fisher scientific announced it would acquire patheon for  billion dosage forms productsedit patheon does not own any of the licences of the products it manufactures and is often listed as the manufacturer on packaging with the product licence holders brand name product name and corporate identity being used patheons clients include such pharmaceutical brands as merck  co novartis and sanofi aventis with biotechnology customers including amgen and avanir pharmaceuticals patheon has manufactured or developed more than  products development activities are undertaken by patheon pharmaceutical development services known as pds a division of patheon inc operating in europe canada and the united states as of  patheon owns manufacturing sites in canada the continental us puerto rico france the united kingdom italy austria germany the netherlands japan and australia patheon manufactures products in various dosage forms oral tablets capsules injectable sterile products vials ampoules prefilled syringes containing liquids powders and lyophilisates and topicals creams ointments drops nasal sprays medicated and nonmedicated gauze referencesedit  leadership patheoncom patheon retrieved may     palmer eric june   updated patheon revenues hit b in first year as part of dpx fiercepharmacom fierce pharma retrieved may     a b company profile patheoncom patheon retrieved may     a b history and milestones patheoncom patheon retrieved may     erman boyd july   long takeover battle a bitter pill for patheon theglobeandmailcom the globe and mail retrieved may     xu jodi november   jll forms new pharma firm with dsm in  billion deal bloombergcom bloomberg retrieved may     a b sites patheoncom patheon retrieved may      takeover failures revisited   httpwwwbizjournalscomtriadblogpatheonchangingbannerpharmacapsnamehtml  jll forms new pharma firm with dsm in  billion deal  november  – via wwwbloombergcom   biopharmareportercom patheon propels itself into us biologics market in gallus acquisition   trlpcpatheon to raise  mln euro loan for irix acquisition  march  – via reuters   httpwwwbizjournalscomportlandmorningcalloregonpharmacompanysoldtonorthcarolinahtml  thermo fisher scientific to acquire patheon for b  gen genetic engineering  biotechnology news  biotech from bench to business  gen gen   patheon by the numbers pdf patheoncom patheon retrieved may    external linksedit patheon home page retrieved from httpsenwikipediaorgwindexphptitlepatheonoldid categories companies established in pharmaceutical companies of the netherlandscompanies based in amsterdamcompanies listed on the new york stock exchange initial public offeringshidden categories pages using deprecated image syntax navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view patheon  wikipedia patheon from wikipedia the free encyclopedia jump to navigation search patheon nv type public company traded as nyse pthn industry contract pharmaceutical services headquarters amsterdam the netherlands key people james c mullen ceo stuart grant cfo and executive vp revenue  billion  number of employees  website wwwpatheoncom patheon nv is a pharmaceutical contract development and manufacturing organization cdmo headquartered in amsterdam it provides contract development and manufacturing services of prescription and overthecounter pharmaceutical products for approximately  pharmaceutical and biotechnology companies it was founded in  as custom pharmaceuticals ltd and changed its name to patheon in  when it was first publicly traded the new york private equity firm jll partners has owned a controlling stake in patheon since  in  patheon merged with the drug manufacturing business of royal dsm nv becoming a jointventure between jll partners and dsm as of  patheon owns manufacturing sites in north america europe japan australia and canada contents  history  dosage forms products  references  external links historyedit patheon was founded in canada in  as custom pharmaceuticals ltd in  it began to expand to us markets custom pharmaceuticals changed its name to patheon in  and was first publicly traded that year on the toronto stock exchange in  patheon acquired mova a drug manufacturer based in puerto rico us the deal proved unprofitable and in  the new york equity firm jll partners provided patheon  million to restructure two years later after a failed takeover bid by lonza group jll partners bought a controlling interest in the company in  patheon acquired banner pharmacaps a drug manufacturer specializing in softgels for  million patheon changed the companys name the following year to banner life sciences in a  billion deal patheon merged with the pharmaceutical division of royal dsm nv in  after jll partners bought a controlling stake in the latter as well adding significantly to patheons european production capacity in  patheon acquired agere pharmaceuticals an oregon us company specializing in drug solubility and irix a maker of specialist active pharmaceutical ingredients in south carolina us the latter for  million in may  thermo fisher scientific announced it would acquire patheon for  billion dosage forms productsedit patheon does not own any of the licences of the products it manufactures and is often listed as the manufacturer on packaging with the product licence holders brand name product name and corporate identity being used patheons clients include such pharmaceutical brands as merck  co novartis and sanofi aventis with biotechnology customers including amgen and avanir pharmaceuticals patheon has manufactured or developed more than  products development activities are undertaken by patheon pharmaceutical development services known as pds a division of patheon inc operating in europe canada and the united states as of  patheon owns manufacturing sites in canada the continental us puerto rico france the united kingdom italy austria germany the netherlands japan and australia patheon manufactures products in various dosage forms oral tablets capsules injectable sterile products vials ampoules prefilled syringes containing liquids powders and lyophilisates and topicals creams ointments drops nasal sprays medicated and nonmedicated gauze referencesedit  leadership patheoncom patheon retrieved may     palmer eric june   updated patheon revenues hit b in first year as part of dpx fiercepharmacom fierce pharma retrieved may     a b company profile patheoncom patheon retrieved may     a b history and milestones patheoncom patheon retrieved may     erman boyd july   long takeover battle a bitter pill for patheon theglobeandmailcom the globe and mail retrieved may     xu jodi november   jll forms new pharma firm with dsm in  billion deal bloombergcom bloomberg retrieved may     a b sites patheoncom patheon retrieved may      takeover failures revisited   httpwwwbizjournalscomtriadblogpatheonchangingbannerpharmacapsnamehtml  jll forms new pharma firm with dsm in  billion deal  november  – via wwwbloombergcom   biopharmareportercom patheon propels itself into us biologics market in gallus acquisition   trlpcpatheon to raise  mln euro loan for irix acquisition  march  – via reuters   httpwwwbizjournalscomportlandmorningcalloregonpharmacompanysoldtonorthcarolinahtml  thermo fisher scientific to acquire patheon for b  gen genetic engineering  biotechnology news  biotech from bench to business  gen gen   patheon by the numbers pdf patheoncom patheon retrieved may    external linksedit patheon home page retrieved from httpsenwikipediaorgwindexphptitlepatheonoldid categories companies established in pharmaceutical companies of the netherlandscompanies based in amsterdamcompanies listed on the new york stock exchange initial public offeringshidden categories pages using deprecated image syntax navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view patheon company profile  leading global cdmo close solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers connect ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts homepage about uscompany profile menu menu solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers connect ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts patheon – a healthier world delivered we believe the world would be a healthier place if tomorrows medicines were made available today patheon is transforming the way pharmaceuticals are made with a simplified endtoend supply chain solution for pharmaceutical and biopharmaceutical companies of all sizes drug substances and drug products development and manufacturing small and large molecules sterile oral solid and softgel dosage forms patheon offers a comprehensive range of services spanning all phases and scales that is wider and deeper than that of any other contract development and manufacturing organization cdmo patheon gives even the smallest pharma and biotech companies instant access to a fully integrated global network of facilities across north america europe asia and australia this includes eleven for commercialscale finished dosage forms four for api process development and manufacturing four for biologics and ten for pharmaceutical development our global leadership is built upon a reputation for scientific and technical excellence this includes specialized capabilities for highly potent and controlled substances aseptic filling and lyophilization complex formulations solubility enhancement and difficult to manufacture apis there is also patheon onesource™ a program that aligns development of drug substance and drug product in a coordinated drive toward proof of concept that can take months off of development timelines patheon has more than  scientific and professional staff and over  years of experience as a leading global cdmo we deliver unrivaled quality reliability and compliance together with more than  clients patheon is rapidly turning pharmaceutical possibilities into reality ampampampampampampltspanampampampampampampgt looking for solutions we can help connect with us do you want to learn more we look forward to learning about your specific needs please contact us usa  global patheon related content patheon overview brochure supply chain management our commitments our leadership solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval  post approval life cycle management about us company profile investor relations our history leadership sites quality our clients our commitments faqs news  press events careers working at patheon job opportunities connect for clients for investors for media members for job seekers ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts   patheon®terms of use privacy statement patheonjp pthn key statistics  patheon nv financial ratios  marketwatch bulletin investor alert london markets open in asia markets currencies us market snapshot expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close patheon nv nyse pthn go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus patheon nv after hours  quotes are delayed by  min jul    pm pthn quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description patheon nv engages in the provision of pharmaceutical development and manufacturing services it operates through the following segments north america drug product services or north america dps europe drug product services or europe dps pharmaceutical development services or pds and drug subs patheon nv engages in the provision of pharmaceutical development and manufacturing services it operates through the following segments north america drug product services or north america dps europe drug product services or europe dps pharmaceutical development services or pds and drug substance services or dss the company was founded on december   and is headquartered in amsterdam netherlands valuation pe current  pe ratio with extraordinary items  pe ratio without extraordinary items  price to sales ratio  price to cash flow ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on total capital  return on invested capital  capital structure total debt to total capital  total debt to total assets  longterm debt to total capital  officers and executives name age officer since title mr paul samuel levy   chairman mr james c mullen   chief executive officer  executive director mr michel lagarde   president mr stuart r grant   chief financial officer  executive vice president mr ray guidotti   svpglobal capacity planning  engineering insider actions – purchase – sale  – number of transactions  date name shares transaction value  michel lagarde president    derivativenonderivative trans at  per share   craig eric schneier executive vice president  cto    derivativenonderivative trans at  per share   raul cardona torres svp quality    derivativenonderivative trans at  per share   james c mullen ceo director    award at  per share   francisco r negron president drug product svcs    award at  per share   michel lagarde president    award at  per share   eric m sherbet general counsel and secretary    award at  per share   lukas utiger president drug substance    award at  per share   michael j lehmann evp sales  marketing    award at  per share   rebecca m holland new evp enterprise operations    award at  per share   dean frederick wilson chief accounting officer    award at  per share   harry r gill svp quality  improvement    award at  per share   pamela daley director    award at  per share   pamela daley director    award at  per share   jeffrey p mcmullen director    award at  per share   william b hayes director    award at  per share   gary p pisano director    award at  per share   hanspeter hasler director    award at  per share   hanspeter hasler director    award at  per share   raul cardona torres svp quality    award at  per share   stephan b tanda director    award at  per share   charles i cogut director    award at  per share   pamela daley director    derivativenonderivative trans at  per share   jeffrey p mcmullen director    derivativenonderivative trans at  per share   william b hayes director    derivativenonderivative trans at  per share   gary p pisano director    derivativenonderivative trans at  per share   hanspeter hasler director    derivativenonderivative trans at  per share   pamela daley director    derivativenonderivative trans at  per share   jeffrey p mcmullen director    derivativenonderivative trans at  per share   william b hayes director    derivativenonderivative trans at  per share   gary p pisano director    derivativenonderivative trans at  per share   hanspeter hasler director    derivativenonderivative trans at  per share   paul samuel levy director    acquisition at  per share   paul samuel levy director    acquisition at  per share   paul samuel levy director    acquisition at  per share   paul samuel levy director    acquisition at  per share   paul samuel levy director    acquisition at  per share   paul samuel levy director    acquisition at  per share   jll partners inc    acquisition at  per share   jll partners inc    acquisition at  per share   pamela daley director    acquisition at  per share   jeffrey p mcmullen director    acquisition at  per share   royal dsm nv    disposition at  per share  newslatestcompanyuspthn marketwatch news on pthn pantheon downgraded to market perform from outperform at raymond james  am june    tomi kilgore patheon downgraded to neutral from overweight at jp morgan  am june    tomi kilgore sp  nasdaq close at records as oil rallies to week high  pm may    sue chang the stockmarket storm is coming—but the reason might surprise investors  am may    shawn langlois thermo fisher to acquire patheon in deal valued at  billion including  billion net debt  am may    ciara linnane patheon shares jump  in premarket trade  am may    ciara linnane thermo fisher has committed debt financing from goldman sachs  am may    ciara linnane thermo fisher expects to finance purchase price with  bln of debt  bln equity  am may    ciara linnane thermo fisher expects to generate  mln of synergies in first full year after close  am may    ciara linnane thermo fisher expects deal to close by year end  am may    ciara linnane thermo fisher expects deal to be immediately and significantly accretive to adj eps  am may    ciara linnane thermo fisher to acquire patheon for  a share or  bln including  bln net debt  am may    ciara linnane pantheon downgraded to sector weight from overweight at keybanc capital  am march    tomi kilgore patheon stock price target cut to  from  at rw baird  am march    tomi kilgore patheon downgraded to neutral from outperform at rw baird  am march    tomi kilgore patheon started at buy at evercore isi  am aug    tomi kilgore patheon started at outperform with  stock price target at raymond james  am aug    tomi kilgore patheon started at overweight with  stock price target at keybanc capital  am aug    tomi kilgore patheon started at overweight with  stock price target at jp morgan  am aug    tomi kilgore patheon started at outperform with  stock price target at rw baird  am aug    tomi kilgore loading more headlines newsnonmarketwatchcompanyuspthn other news on pthn thermo fisher prices €b debt offering for patheon buyout  pm july    seeking alpha european deal making set to rise despite political uncertainty  am july    the wall street journal interactive edition q patheon nv  pm june    edgar online  edg  q k premarket analyst action  healthcare  am june    seeking alpha premarket analyst action  healthcare  am june    seeking alpha mergers and acquisitions  capturing the gain of acquirees  am may    seeking alpha tracking ole andreas halvorsens viking global portfolio  q  update  am may    seeking alpha thermo fisher  multiyear dealmaking spree continues with patheon deal  pm may    seeking alpha company news for may    am may    zackscom why fireeye patheon and vista outdoor jumped today  pm may    motley fool thermo fisher to buy patheon for  billion  pm may    the wall street journal interactive edition patheon nv pthn stock soars on thermo fisher scientific inc tmo deal  pm may    investorplacecom why patheon nv is soaring today  am may    motley fool pantheon up  premarket on b thermo fisher bid  am may    seeking alpha wall street breakfast cybersecurity stocks in focus  am may    seeking alpha thermo fisher in talks to buy patheon  am may    seeking alpha patheons execution needs to match its potential  am may    seeking alpha should you get rid of patheon pthn now  am march    zackscom inc research a toptier cro at a lowtier price  am march    seeking alpha catalents price is a little hard to swallow  pm march    seeking alpha loading more headlines at a glance patheon nv herengracht  amsterdam noordholland  bt phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue b net income m  sales growth  employees  annual report for pthn newspressreleasecompanyuspthn press releases on pthn faruqi  faruqi llp announces filing of a class action lawsuit against patheon nv  pm july    globenewswire technical snapshots for these generic drugs stocks  mallinckrodt patheon zoetis and innocoll  am july    pr newswire  prf patheon to invest  million expanding capabilities to support continued growth  pm june    businesswire  bzx earnings review and free research report patheons q results topped estimates to be acquired by thermo fisher  am june    accesswire shareholder notice brodsky  smith llc announces an investigation of patheon nv  pthn  pm june    accesswire shareholder alert levi  korsinsky llp announces an investigation concerning whether the sale of patheon nv to thermo fisher scientific inc is fair to shareholders  am june    businesswire  bzx shareholder alert monteverde  associates pc announces an investigation of patheon nv  pthn  pm june    pr newswire  prf how these healthcare stocks are faring  pfizer zoetis mallinckrodt and patheon  am may    pr newswire  prf blog coverage thermo fisher to acquire patheon expects to realize multiple synergies from the transaction  am may    accesswire thermo fisher scientific to acquire patheon a leading contract development and manufacturing organization cdmo  am may    pr newswire  prf patheon completes sterile expansion project at greenville nc manufacturing site  am may    businesswire  bzx how these generic drugs stocks are faring  zynerba pharma patheon scynexis and flexion therapeutics  am april    pr newswire  prf patheon achieved more outsourced new drug approvals than any other provider according to  pharmsource cmo scorecard  am march    businesswire  bzx blog coverage allergan and parateks acne drug reported positive results  am march    accesswire patheon to announce first quarter fiscal year  financial results on march    am march    businesswire  bzx patheonnamed supply chain resiliency partner of the year  am march    businesswire  bzx correcting and replacing photo patheon announces completion of its acquisition of stateoftheart manufacturing site  am feb    businesswire  bzx patheon announces completion of its acquisition of stateoftheart manufacturing site  am feb    businesswire  bzx patheon to participate in the th annual jp morgan healthcare conference  am jan    businesswire  bzx correcting and replacing patheon to announce fourth quarter and fiscal year  financial results on december   company to provide fiscal  outlook  am dec    businesswire  bzx loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest asantander profit rises upbeat on banco popular abnp paribas profit falls but beats views abt earnings fall on higher costs backs guidance aair franceklm profit rises on higher airfares ajapan inflation up but falls short of  target avale doesnt see samarco jv restarting in  auk consumer confidence slips again unexpectedly aexlehman trader denied bulk of  million bonus aporsche told to recall cars with defeat devices asenate votes against skinny bill to repeal obamacare asenate majority leader mcconnell re healthcare vote this is a disappointment asenate vote to repeal portions of health care law known as obamacare fails asenate voting underway over repealing portions of aca known as obamacare ascaramucci provides a shocking bannon comparison that defies anatomy abaidu posts first profit in three years aoil pauses ahead of us rig data after logging nearly  gain for the week acredit suisse profit rises revenue up slightly aubs net profit up as revenues inch past forecasts aasian stocks tumble on heels of us tech selloff pscaramucci says trump’s love of pizza shows he’s not an elitist —  ways rich people act humble loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  patheon nv company profile  bloomberg feedback patheon nv public company company profile sector health care industry biotech  pharma subindustry specialty pharma patheon nv operates as a provider of outsourced pharmaceutical development and manufacturing services the company offers customizable range of active pharmaceutical ingredient and finished drug product services to customers from formulation development to clinical and commercialscale manufacturing packaging and life cycle management corporate information address herengracht  amsterdam bt netherlands phone  fax  web url wwwpatheoncom board members chairman company paul levy jll partners inc chief executive officer company james mullen percivia llc exec vpcfo company stuart grant patheon nv secretarygeneral counsel company board members company jeffrey mcmullen inventiv health inc hans hasler perrigo corp ltd daniel agroskin jll partners inc stephan tanda aptargroup inc show more from the web pthn news press releases thermo fisher extends binge with  billion patheon deal may   thermo fisher scientific said in talks to acquire patheon may   thermo fisher scientific prices offering of eurodenominated senior notes jul   faruqi  faruqi llp announces filing of a class action lawsuit against patheon nv jul   patheon to invest  million expanding capabilities to support continued growth jun   shareholder alert levi  korsinsky llp announces an investigation concerning whether the sale of patheon nv to thermo fisher jun   shareholder alert monteverde  associates pc announces an investigation of patheon nv  pthn jun   patheon reports fiscal  second quarter jun   ma  pe  insights powered by data  united states  may  jun   fortress biotech subsidiary caelum biosciences enters biopharmaceutical manufacturing agreement with patheon jun   key executives james c mullen jim chief executive officer michel lagarde president franco negron presidentdrug product lukas utiger presidentdrug substance stuart grant exec vpcfo rebecca holland new exec vpcommunications michael j lehmann mike exec vpglobal sales  mktg michael e lytton exec vpcorporate dev  strategy antonio magnelli senior vpdrug product europe harry r gill iii senior vpquality  improvement raul cardona torres senior vpquality tyler d gronbach vpcommunications  investor relations eric m sherbet secretarygeneral counsel show more show less sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data pthn stock price  patheon nv stock quote us nyse  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern a santander profit rises upbeat on banco popular a bnp paribas profit falls but beats views a bt earnings fall on higher costs backs guidance a air franceklm profit rises on higher airfares a japan inflation up but falls short of  target a vale doesnt see samarco jv restarting in  a uk consumer confidence slips again unexpectedly a exlehman trader denied bulk of  million bonus a porsche told to recall cars with defeat devices a senate votes against skinny bill to repeal obamacare to be replaced home investing quotes stocks united states pthn overview compare quotes stock screener earnings calendar sectors nyse pthn us nyse join td ameritrade find a broker patheon nv watchlist createpthnalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap b shares outstanding m public float m beta  rev per employee na pe ratio  eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones pantheon downgraded to market perform from outperform at raymond james pantheon downgraded to market perform from outperform at raymond james jun   at  am et by tomi kilgore patheon downgraded to neutral from overweight at jp morgan patheon downgraded to neutral from overweight at jp morgan jun   at  am et by tomi kilgore sp  nasdaq close at records as oil rallies to week high may   at  pm et by sara sjolin the stockmarket storm is coming—but the reason might surprise investors may   at  am et by shawn langlois thermo fisher to acquire patheon in deal valued at  billion including  billion net debt thermo fisher scientific inc said monday it has agreed to acquire patheon nv for  a share or  billion including  billion of net debt thermo fisher which offers services to help with research and laboratory productivity said it expects the deal to be immediately and significantly accretive to adjusted pershare earnings adding  cents in the first full year after close patheon offers complex development and manufacturing services cdmo to biopharmaceutical companies the combination will give thermo fisher a foothold in the highgrowth cdmo market which it estimates is worth about  billion patheon has about  employees worldwide and generated  revenue of about  billion the deal is expected to close by yearend thermo fisher has committed debt financing from goldman sachs and expects to finance the deal with about  billion of debt and  billion of equity patheon shares jumped  premarket on the news thermo fisher was not yet active but has gained  in  outperforming the sp   which has gained about  may   at  am et by ciara linnane patheon shares jump  in premarket trade patheon shares jump  in premarket trade may   at  am et by ciara linnane thermo fisher expects to finance purchase price with  bln of debt  bln equity thermo fisher expects to finance purchase price with  bln of debt  bln equity may   at  am et by ciara linnane thermo fisher has committed debt financing from goldman sachs thermo fisher has committed debt financing from goldman sachs may   at  am et by ciara linnane thermo fisher expects deal to close by year end thermo fisher expects deal to close by year end may   at  am et by ciara linnane thermo fisher expects to generate  mln of synergies in first full year after close thermo fisher expects to generate  mln of synergies in first full year after close may   at  am et by ciara linnane thermo fisher expects deal to be immediately and significantly accretive to adj eps thermo fisher expects deal to be immediately and significantly accretive to adj eps may   at  am et by ciara linnane thermo fisher to acquire patheon for  a share or  bln including  bln net debt thermo fisher to acquire patheon for  a share or  bln including  bln net debt may   at  am et by ciara linnane pantheon downgraded to sector weight from overweight at keybanc capital mar   at  am et by tomi kilgore patheon stock price target cut to  from  at rw baird mar   at  am et by tomi kilgore patheon downgraded to neutral from outperform at rw baird mar   at  am et by tomi kilgore patheon started at buy at evercore isi aug   at  am et by tomi kilgore patheon started at outperform with  stock price target at raymond james aug   at  am et by tomi kilgore patheon started at overweight with  stock price target at keybanc capital aug   at  am et by tomi kilgore patheon started at overweight with  stock price target at jp morgan aug   at  am et by tomi kilgore patheon started at outperform with  stock price target at rw baird aug   at  am et by tomi kilgore european deal making set to rise despite political uncertainty european deal making is set to march on in the second half of the year despite britain’s latest election surprise and early signs of an acrimonious breakup with the european union jun   at  pm et on the wall street journal thermo fisher to buy patheon for  billion labequipment company thermo fisher scientific inc said monday it would buy drugdevelopment technology company patheon nv in a deal worth about  billion may   at  pm et on the wall street journal stocks to watch thermo fisher moody’s amazon among the companies with shares expected to trade actively in mondays session are thermo fisher scientific inc patheon nv and moodys corp may   at  am et on the wall street journal higher rates a risk for some life sciences stocks dec   at  pm et on barrons recent news other news press releases thermo fisher prices €b debt offering for patheon buyout thermo fisher prices €b debt offering for patheon buyout jul   at  pm et on seeking alpha european deal making set to rise despite political uncertainty european deal making is set to march on in the second half of the year despite britain’s latest election surprise and early signs of an acrimonious breakup with the european union jun   at  pm et on the wall street journal q patheon nv q patheon nv jun   at  pm et on edgar online  edg  q k premarket analyst action  healthcare premarket analyst action  healthcare jun   at  am et on seeking alpha premarket analyst action  healthcare premarket analyst action  healthcare jun   at  am et on seeking alpha mergers and acquisitions  capturing the gain of acquirees mergers and acquisitions  capturing the gain of acquirees may   at  am et on seeking alpha tracking ole andreas halvorsens viking global portfolio  q  update tracking ole andreas halvorsens viking global portfolio  q  update may   at  am et on seeking alpha company news for may   companies in the news are pthntmomcoualwdctosyy may   at  am et on zackscom thermo fisher  multiyear dealmaking spree continues with patheon deal thermo fisher  multiyear dealmaking spree continues with patheon deal may   at  pm et on seeking alpha why fireeye patheon and vista outdoor jumped today may   at  pm et on motley fool thermo fisher to buy patheon for  billion labequipment company thermo fisher scientific inc said monday it would buy drugdevelopment technology company patheon nv in a deal worth about  billion may   at  pm et on the wall street journal patheon nv pthn stock soars on thermo fisher scientific inc tmo deal patheon nv pthn stock soars on thermo fisher scientific inc tmo deal may   at  pm et on investorplacecom why patheon nv is soaring today may   at  am et on motley fool pantheon up  premarket on b thermo fisher bid pantheon up  premarket on b thermo fisher bid may   at  am et on seeking alpha wall street breakfast cybersecurity stocks in focus wall street breakfast cybersecurity stocks in focus may   at  am et on seeking alpha thermo fisher in talks to buy patheon thermo fisher in talks to buy patheon may   at  am et on seeking alpha patheons execution needs to match its potential patheons execution needs to match its potential may   at  am et on seeking alpha should you get rid of patheon pthn now mar   at  am et on zackscom inc research a toptier cro at a lowtier price mar   at  am et on seeking alpha catalents price is a little hard to swallow mar   at  pm et on seeking alpha faruqi  faruqi llp announces filing of a class action lawsuit against patheon nv faruqi  faruqi llp announces filing of a class action lawsuit against patheon nv jul   at  pm et on globenewswire technical snapshots for these generic drugs stocks  mallinckrodt patheon zoetis and innocoll technical snapshots for these generic drugs stocks  mallinckrodt patheon zoetis and innocoll jul   at  am et on pr newswire  prf patheon to invest  million expanding capabilities to support continued growth patheon to invest  million expanding capabilities to support continued growth jun   at  pm et on businesswire  bzx earnings review and free research report patheons q results topped estimates to be acquired by thermo fisher earnings review and free research report patheons q results topped estimates to be acquired by thermo fisher jun   at  am et on accesswire shareholder notice brodsky  smith llc announces an investigation of patheon nv  pthn shareholder notice brodsky  smith llc announces an investigation of patheon nv  pthn jun   at  pm et on accesswire shareholder alert levi  korsinsky llp announces an investigation concerning whether the sale of patheon nv to thermo fisher scientific inc is fair to shareholders shareholder alert levi  korsinsky llp announces an investigation concerning whether the sale of patheon nv to thermo fisher scientific inc is fair to shareholders jun   at  am et on businesswire  bzx shareholder alert monteverde  associates pc announces an investigation of patheon nv  pthn shareholder alert monteverde  associates pc announces an investigation of patheon nv  pthn jun   at  pm et on pr newswire  prf how these healthcare stocks are faring  pfizer zoetis mallinckrodt and patheon how these healthcare stocks are faring  pfizer zoetis mallinckrodt and patheon may   at  am et on pr newswire  prf blog coverage thermo fisher to acquire patheon expects to realize multiple synergies from the transaction blog coverage thermo fisher to acquire patheon expects to realize multiple synergies from the transaction may   at  am et on accesswire thermo fisher scientific to acquire patheon a leading contract development and manufacturing organization cdmo thermo fisher scientific to acquire patheon a leading contract development and manufacturing organization cdmo may   at  am et on pr newswire  prf patheon completes sterile expansion project at greenville nc manufacturing site patheon completes sterile expansion project at greenville nc manufacturing site may   at  am et on businesswire  bzx how these generic drugs stocks are faring  zynerba pharma patheon scynexis and flexion therapeutics apr   at  am et on pr newswire  prf patheon achieved more outsourced new drug approvals than any other provider according to  pharmsource cmo scorecard mar   at  am et on businesswire  bzx blog coverage allergan and parateks acne drug reported positive results mar   at  am et on accesswire patheon to announce first quarter fiscal year  financial results on march   mar   at  am et on businesswire  bzx patheonnamed supply chain resiliency partner of the year mar   at  am et on businesswire  bzx correcting and replacing photo patheon announces completion of its acquisition of stateoftheart manufacturing site feb   at  am et on businesswire  bzx patheon announces completion of its acquisition of stateoftheart manufacturing site feb   at  am et on businesswire  bzx patheon to participate in the th annual jp morgan healthcare conference jan   at  am et on businesswire  bzx correcting and replacing patheon to announce fourth quarter and fiscal year  financial results on december   company to provide fiscal  outlook dec   at  am et on businesswire  bzx patheon nv patheon nv engages in the provision of pharmaceutical development and manufacturing services it operates through the following segments north america drug product services or north america dps europe drug product services or europe dps pharmaceutical development services or pds and drug substance services or dss the company was founded on december   and is headquartered in amsterdam netherlands see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top upgrades downgrades for june   jun   at  am et on benzingacom benzingas top upgrades downgrades for may   may   at  am et on benzingacom  biggest price target changes for friday mar   at  am et on benzingacom competitors name chg  market cap omeros corp  m ohr pharmaceutical inc  m oncomed pharmaceuticals inc  m omni bio pharmaceutical inc  m competitor data provided by partner content trending tickers powered by amzn  spy  sbux  dvax  aapl  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert london markets open in asia markets currencies us market snapshot stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest asantander profit rises upbeat on banco popular abnp paribas profit falls but beats views abt earnings fall on higher costs backs guidance aair franceklm profit rises on higher airfares ajapan inflation up but falls short of  target avale doesnt see samarco jv restarting in  auk consumer confidence slips again unexpectedly aexlehman trader denied bulk of  million bonus aporsche told to recall cars with defeat devices asenate votes against skinny bill to repeal obamacare asenate majority leader mcconnell re healthcare vote this is a disappointment asenate vote to repeal portions of health care law known as obamacare fails asenate voting underway over repealing portions of aca known as obamacare ascaramucci provides a shocking bannon comparison that defies anatomy abaidu posts first profit in three years aoil pauses ahead of us rig data after logging nearly  gain for the week acredit suisse profit rises revenue up slightly aubs net profit up as revenues inch past forecasts aasian stocks tumble on heels of us tech selloff pscaramucci says trump’s love of pizza shows he’s not an elitist —  ways rich people act humble loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert london markets open in asia markets currencies us market snapshot stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest asantander profit rises upbeat on banco popular abnp paribas profit falls but beats views abt earnings fall on higher costs backs guidance aair franceklm profit rises on higher airfares ajapan inflation up but falls short of  target avale doesnt see samarco jv restarting in  auk consumer confidence slips again unexpectedly aexlehman trader denied bulk of  million bonus aporsche told to recall cars with defeat devices asenate votes against skinny bill to repeal obamacare asenate majority leader mcconnell re healthcare vote this is a disappointment asenate vote to repeal portions of health care law known as obamacare fails asenate voting underway over repealing portions of aca known as obamacare ascaramucci provides a shocking bannon comparison that defies anatomy abaidu posts first profit in three years aoil pauses ahead of us rig data after logging nearly  gain for the week acredit suisse profit rises revenue up slightly aubs net profit up as revenues inch past forecasts aasian stocks tumble on heels of us tech selloff pscaramucci says trump’s love of pizza shows he’s not an elitist —  ways rich people act humble loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert london markets open in asia markets currencies us market snapshot stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest asantander profit rises upbeat on banco popular abnp paribas profit falls but beats views abt earnings fall on higher costs backs guidance aair franceklm profit rises on higher airfares ajapan inflation up but falls short of  target avale doesnt see samarco jv restarting in  auk consumer confidence slips again unexpectedly aexlehman trader denied bulk of  million bonus aporsche told to recall cars with defeat devices asenate votes against skinny bill to repeal obamacare asenate majority leader mcconnell re healthcare vote this is a disappointment asenate vote to repeal portions of health care law known as obamacare fails asenate voting underway over repealing portions of aca known as obamacare ascaramucci provides a shocking bannon comparison that defies anatomy abaidu posts first profit in three years aoil pauses ahead of us rig data after logging nearly  gain for the week acredit suisse profit rises revenue up slightly aubs net profit up as revenues inch past forecasts aasian stocks tumble on heels of us tech selloff pscaramucci says trump’s love of pizza shows he’s not an elitist —  ways rich people act humble loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  pthn stock price  patheon nv stock quote us nyse  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern a santander profit rises upbeat on banco popular a bnp paribas profit falls but beats views a bt earnings fall on higher costs backs guidance a air franceklm profit rises on higher airfares a japan inflation up but falls short of  target a vale doesnt see samarco jv restarting in  a uk consumer confidence slips again unexpectedly a exlehman trader denied bulk of  million bonus a porsche told to recall cars with defeat devices a senate votes against skinny bill to repeal obamacare to be replaced home investing quotes stocks united states pthn overview compare quotes stock screener earnings calendar sectors nyse pthn us nyse join td ameritrade find a broker patheon nv watchlist createpthnalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap b shares outstanding m public float m beta  rev per employee na pe ratio  eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones pantheon downgraded to market perform from outperform at raymond james pantheon downgraded to market perform from outperform at raymond james jun   at  am et by tomi kilgore patheon downgraded to neutral from overweight at jp morgan patheon downgraded to neutral from overweight at jp morgan jun   at  am et by tomi kilgore sp  nasdaq close at records as oil rallies to week high may   at  pm et by sara sjolin the stockmarket storm is coming—but the reason might surprise investors may   at  am et by shawn langlois thermo fisher to acquire patheon in deal valued at  billion including  billion net debt thermo fisher scientific inc said monday it has agreed to acquire patheon nv for  a share or  billion including  billion of net debt thermo fisher which offers services to help with research and laboratory productivity said it expects the deal to be immediately and significantly accretive to adjusted pershare earnings adding  cents in the first full year after close patheon offers complex development and manufacturing services cdmo to biopharmaceutical companies the combination will give thermo fisher a foothold in the highgrowth cdmo market which it estimates is worth about  billion patheon has about  employees worldwide and generated  revenue of about  billion the deal is expected to close by yearend thermo fisher has committed debt financing from goldman sachs and expects to finance the deal with about  billion of debt and  billion of equity patheon shares jumped  premarket on the news thermo fisher was not yet active but has gained  in  outperforming the sp   which has gained about  may   at  am et by ciara linnane patheon shares jump  in premarket trade patheon shares jump  in premarket trade may   at  am et by ciara linnane thermo fisher expects to finance purchase price with  bln of debt  bln equity thermo fisher expects to finance purchase price with  bln of debt  bln equity may   at  am et by ciara linnane thermo fisher has committed debt financing from goldman sachs thermo fisher has committed debt financing from goldman sachs may   at  am et by ciara linnane thermo fisher expects deal to close by year end thermo fisher expects deal to close by year end may   at  am et by ciara linnane thermo fisher expects to generate  mln of synergies in first full year after close thermo fisher expects to generate  mln of synergies in first full year after close may   at  am et by ciara linnane thermo fisher expects deal to be immediately and significantly accretive to adj eps thermo fisher expects deal to be immediately and significantly accretive to adj eps may   at  am et by ciara linnane thermo fisher to acquire patheon for  a share or  bln including  bln net debt thermo fisher to acquire patheon for  a share or  bln including  bln net debt may   at  am et by ciara linnane pantheon downgraded to sector weight from overweight at keybanc capital mar   at  am et by tomi kilgore patheon stock price target cut to  from  at rw baird mar   at  am et by tomi kilgore patheon downgraded to neutral from outperform at rw baird mar   at  am et by tomi kilgore patheon started at buy at evercore isi aug   at  am et by tomi kilgore patheon started at outperform with  stock price target at raymond james aug   at  am et by tomi kilgore patheon started at overweight with  stock price target at keybanc capital aug   at  am et by tomi kilgore patheon started at overweight with  stock price target at jp morgan aug   at  am et by tomi kilgore patheon started at outperform with  stock price target at rw baird aug   at  am et by tomi kilgore european deal making set to rise despite political uncertainty european deal making is set to march on in the second half of the year despite britain’s latest election surprise and early signs of an acrimonious breakup with the european union jun   at  pm et on the wall street journal thermo fisher to buy patheon for  billion labequipment company thermo fisher scientific inc said monday it would buy drugdevelopment technology company patheon nv in a deal worth about  billion may   at  pm et on the wall street journal stocks to watch thermo fisher moody’s amazon among the companies with shares expected to trade actively in mondays session are thermo fisher scientific inc patheon nv and moodys corp may   at  am et on the wall street journal higher rates a risk for some life sciences stocks dec   at  pm et on barrons recent news other news press releases thermo fisher prices €b debt offering for patheon buyout thermo fisher prices €b debt offering for patheon buyout jul   at  pm et on seeking alpha european deal making set to rise despite political uncertainty european deal making is set to march on in the second half of the year despite britain’s latest election surprise and early signs of an acrimonious breakup with the european union jun   at  pm et on the wall street journal q patheon nv q patheon nv jun   at  pm et on edgar online  edg  q k premarket analyst action  healthcare premarket analyst action  healthcare jun   at  am et on seeking alpha premarket analyst action  healthcare premarket analyst action  healthcare jun   at  am et on seeking alpha mergers and acquisitions  capturing the gain of acquirees mergers and acquisitions  capturing the gain of acquirees may   at  am et on seeking alpha tracking ole andreas halvorsens viking global portfolio  q  update tracking ole andreas halvorsens viking global portfolio  q  update may   at  am et on seeking alpha company news for may   companies in the news are pthntmomcoualwdctosyy may   at  am et on zackscom thermo fisher  multiyear dealmaking spree continues with patheon deal thermo fisher  multiyear dealmaking spree continues with patheon deal may   at  pm et on seeking alpha why fireeye patheon and vista outdoor jumped today may   at  pm et on motley fool thermo fisher to buy patheon for  billion labequipment company thermo fisher scientific inc said monday it would buy drugdevelopment technology company patheon nv in a deal worth about  billion may   at  pm et on the wall street journal patheon nv pthn stock soars on thermo fisher scientific inc tmo deal patheon nv pthn stock soars on thermo fisher scientific inc tmo deal may   at  pm et on investorplacecom why patheon nv is soaring today may   at  am et on motley fool pantheon up  premarket on b thermo fisher bid pantheon up  premarket on b thermo fisher bid may   at  am et on seeking alpha wall street breakfast cybersecurity stocks in focus wall street breakfast cybersecurity stocks in focus may   at  am et on seeking alpha thermo fisher in talks to buy patheon thermo fisher in talks to buy patheon may   at  am et on seeking alpha patheons execution needs to match its potential patheons execution needs to match its potential may   at  am et on seeking alpha should you get rid of patheon pthn now mar   at  am et on zackscom inc research a toptier cro at a lowtier price mar   at  am et on seeking alpha catalents price is a little hard to swallow mar   at  pm et on seeking alpha faruqi  faruqi llp announces filing of a class action lawsuit against patheon nv faruqi  faruqi llp announces filing of a class action lawsuit against patheon nv jul   at  pm et on globenewswire technical snapshots for these generic drugs stocks  mallinckrodt patheon zoetis and innocoll technical snapshots for these generic drugs stocks  mallinckrodt patheon zoetis and innocoll jul   at  am et on pr newswire  prf patheon to invest  million expanding capabilities to support continued growth patheon to invest  million expanding capabilities to support continued growth jun   at  pm et on businesswire  bzx earnings review and free research report patheons q results topped estimates to be acquired by thermo fisher earnings review and free research report patheons q results topped estimates to be acquired by thermo fisher jun   at  am et on accesswire shareholder notice brodsky  smith llc announces an investigation of patheon nv  pthn shareholder notice brodsky  smith llc announces an investigation of patheon nv  pthn jun   at  pm et on accesswire shareholder alert levi  korsinsky llp announces an investigation concerning whether the sale of patheon nv to thermo fisher scientific inc is fair to shareholders shareholder alert levi  korsinsky llp announces an investigation concerning whether the sale of patheon nv to thermo fisher scientific inc is fair to shareholders jun   at  am et on businesswire  bzx shareholder alert monteverde  associates pc announces an investigation of patheon nv  pthn shareholder alert monteverde  associates pc announces an investigation of patheon nv  pthn jun   at  pm et on pr newswire  prf how these healthcare stocks are faring  pfizer zoetis mallinckrodt and patheon how these healthcare stocks are faring  pfizer zoetis mallinckrodt and patheon may   at  am et on pr newswire  prf blog coverage thermo fisher to acquire patheon expects to realize multiple synergies from the transaction blog coverage thermo fisher to acquire patheon expects to realize multiple synergies from the transaction may   at  am et on accesswire thermo fisher scientific to acquire patheon a leading contract development and manufacturing organization cdmo thermo fisher scientific to acquire patheon a leading contract development and manufacturing organization cdmo may   at  am et on pr newswire  prf patheon completes sterile expansion project at greenville nc manufacturing site patheon completes sterile expansion project at greenville nc manufacturing site may   at  am et on businesswire  bzx how these generic drugs stocks are faring  zynerba pharma patheon scynexis and flexion therapeutics apr   at  am et on pr newswire  prf patheon achieved more outsourced new drug approvals than any other provider according to  pharmsource cmo scorecard mar   at  am et on businesswire  bzx blog coverage allergan and parateks acne drug reported positive results mar   at  am et on accesswire patheon to announce first quarter fiscal year  financial results on march   mar   at  am et on businesswire  bzx patheonnamed supply chain resiliency partner of the year mar   at  am et on businesswire  bzx correcting and replacing photo patheon announces completion of its acquisition of stateoftheart manufacturing site feb   at  am et on businesswire  bzx patheon announces completion of its acquisition of stateoftheart manufacturing site feb   at  am et on businesswire  bzx patheon to participate in the th annual jp morgan healthcare conference jan   at  am et on businesswire  bzx correcting and replacing patheon to announce fourth quarter and fiscal year  financial results on december   company to provide fiscal  outlook dec   at  am et on businesswire  bzx patheon nv patheon nv engages in the provision of pharmaceutical development and manufacturing services it operates through the following segments north america drug product services or north america dps europe drug product services or europe dps pharmaceutical development services or pds and drug substance services or dss the company was founded on december   and is headquartered in amsterdam netherlands see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top upgrades downgrades for june   jun   at  am et on benzingacom benzingas top upgrades downgrades for may   may   at  am et on benzingacom  biggest price target changes for friday mar   at  am et on benzingacom competitors name chg  market cap omeros corp  m ohr pharmaceutical inc  m oncomed pharmaceuticals inc  m omni bio pharmaceutical inc  m competitor data provided by partner content trending tickers powered by amzn  spy  sbux  dvax  aapl  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience patheon online newsroom  close solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers ideas in action ask the experts brochures  scientific posters articles  white papers videos recorded webcasts homepage  newsroom  menu menu solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers ideas in action ask the experts brochures  scientific posters articles  white papers videos recorded webcasts login patheon newsroom  jun  patheon to invest  million expanding capabilities to support continued growth investments in key service areas to meet growing customer demand patheon nv nyse pthn a leading global provider of highquality drug development and delivery solutions to the pharmaceutical sector today announced that it expects to invest approximately  million at key sites across its global network to meet growing customer  jun  patheon reports fiscal  second quarter highlights q  revenue of  million net income from continuing operations of  million net income from continuing operations per diluted share of  q  adjusted ebitda of  million adjusted net income from continuing operations of  million adjusted net income from continuing operations per diluted share of  patheon nv nyse pthn a leading global provider of pharmaceutical development and manufacturing services today reported financial results for the quarter ended april    may  thermo fisher scientific to acquire patheon a leading contract development and manufacturing organization cdmo  patheon provides entry into the attractive highgrowth cdmo market  combination significantly strengthens thermo fishers unique value proposition for pharmaceutical and biotech customers by adding highly complementary services  creates substantial synergies and positions combined company to further accelerate growth  expected to be immediately and significantly accretive to adjusted earnings per share eps thermo fisher scientific inc nyse tmo the world leader in serving science and patheon nv nyse pthn a leading global provider of highquality drug development and delivery solutions to the pharmaceutical and biopharma sectors today announced that their boards of directors have approved thermo news releases multimedia company profile ideas in action newsroom home patheon newsroom company profilefaq leadership news releases videos fact sheet ideas in actionbrochures email alerts media contact mari mansfield emperor blvd durham nc    marimansfieldpatheoncom sign up for email alerts search search this site advanced search patheon on twitter parrish galliher cto at upstream of ge healthcare life sciences with industry manufacturing recommendations httpstcocukwjscd —  hours  min ago from outsourcedpharm – patheons franco negron explains the pharma industrys need for more products details… httpstcoryvuazodig —  day  hours ago rt medicinemaker charlotte barker speaks with lukas utiger from patheon httpstcovpgaxo httpstcosadlmeef —  day  hours ago our goal is ahealthierworld for all – to enjoy both the big events and the little moments in life httpstcolirjppyj —  days  hours ago rt medicinemaker steve lam shares his lessons learned over  decades in pharma patheon httpstcodutuhspki httpstcoazeqlhksh —  days  hours ago    of  ›› more     newsroom home patheon newsroom company profilefaq leadership news releases videos fact sheet ideas in actionbrochures email alerts media contact mari mansfield emperor blvd durham nc    marimansfieldpatheoncom sign up for email alerts search search this site advanced search patheon on twitter parrish galliher cto at upstream of ge healthcare life sciences with industry manufacturing recommendations httpstcocukwjscd —  hours  min ago from outsourcedpharm – patheons franco negron explains the pharma industrys need for more products details… httpstcoryvuazodig —  day  hours ago rt medicinemaker charlotte barker speaks with lukas utiger from patheon httpstcovpgaxo httpstcosadlmeef —  day  hours ago our goal is ahealthierworld for all – to enjoy both the big events and the little moments in life httpstcolirjppyj —  days  hours ago rt medicinemaker steve lam shares his lessons learned over  decades in pharma patheon httpstcodutuhspki httpstcoazeqlhksh —  days  hours ago    of  ›› more related content patheon overview brochure supply chain management our commitments our leadership solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval  post approval life cycle management about us company profile investor relations our history leadership sites quality our clients our commitments faqs news  press events careers working at patheon job opportunities connect for clients for investors for media members ideas in action ask the experts brochures  scientific posters articles  white papers videos recorded webcasts   patheon® terms of use privacy statement patheonjp business wire newshqsm patheon nv private company information  bloomberg july    am et life sciences tools and services company overview of patheon nv snapshot people company overview patheon nv provides outsourced pharmaceutical development and manufacturing services in the netherlands the company operates through three segments drug product services pharmaceutical development services and drug substance services it offers a range of active pharmaceutical ingredient and finished drug product services including formulation development as well as clinical and commercialscale manufacturing packaging and lifecycle management it caters its services to small molecule and large molecule biological drugs sectors the company was formerly known as patheon holdings coöperatief ua and changed its names to patheon nv in june  patheon nv was incorporated in  patheon nv provides outsourced pharmaceutical development and manufacturing services in the netherlands the company operates through three segments drug product services pharmaceutical development services and drug substance services it offers a range of active pharmaceutical ingredient and finished drug product services including formulation development as well as clinical and commercialscale manufacturing packaging and lifecycle management it caters its services to small molecule and large molecule biological drugs sectors the company was formerly known as patheon holdings coöperatief ua and changed its names to patheon nv in june  patheon nv was incorporated in  and is headquartered in durham north carolina detailed description  emperor boulevardsuite durham nc united statesfounded in  employees phone    fax    wwwpatheoncom key executives for patheon nv mr james c mullen ceo  executive director age  total annual compensation m mr michel lagarde president age  total annual compensation k mr stuart r grant executive vp  cfo age  total annual compensation k mr francisco r negron senior vice president of the cmo business for north america age  total annual compensation k dr lukas utiger phd president of drug substance services age  total annual compensation k compensation as of fiscal year  patheon nv key developments patheon nv provides earnings guidance for the year ending october   to october   jul   patheon nv provided earnings guidance for the year ending october   to october   for the year  the company expects total revenues of  million total adjusted ebitda of  million interest expense  million income tax expense of  million da of  million and net income of  million for the year  the company expects total revenues of  million total adjusted ebitda of  million interest expense  million income tax expense of  million da of  million and net income of  million for the year  the company expects total revenues of  million total adjusted ebitda of  million interest expense  million income tax expense of  million da of  million and net income of  million for the year  the company expects total revenues of  million total adjusted ebitda of  million interest expense  million income tax expense of  million da of  million and net income of  million for the year  the company expects total revenues of  million total adjusted ebitda of  million interest expense  million income tax expense of  million da of  million and net income of  million patheon to invest  million for expanding capabilities to support continued growth jun   patheon nv announced that it expects to invest approximately  million at key sites across its global network to meet growing customer demand for expanded service capabilities patheon nv reports unaudited consolidated earnings results for the second quarter and six months ended april   jun   patheon nv reported unaudited consolidated earnings results for the second quarter and six months ended april   for the quarter the company reported revenues of  million against  million a year ago operating income was  million against  million a year ago income before income taxes was  million against  million a year ago net income from continuing operations was  million or  per share diluted against  million or  per share diluted a year ago net income was  million against  million a year ago total adjusted ebitda was  million against  million a year ago adjusted net income was  million or  per share diluted against  million or  per share diluted a year ago for the six months the company reported revenues of  million against  million a year ago operating income was  million against  million a year ago income before income taxes was  million against loss before income taxes of  million a year ago net income from continuing operations was  million or  per share diluted against net loss from continuing operations of  million or  per share diluted a year ago net income was  million against net loss of  million a year ago cash provided by operating activities was  million against net cash used in operating activities of  million a year ago additions to capital assets were  million against  million a year ago total adjusted ebitda was  million against  million a year ago adjusted net income was  million or  per share diluted against  million or  per share diluted a year ago similar private companies by industry company name region x genomics inc united states g clinical inc united states aapharmasyn llc united states abiant inc united states abiobot inc united states recent private companies transactions typedate target mergeracquisition may    request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact patheon nv please visit wwwpatheoncom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close patheon nv announces pricing of initial public offering  patheon online newsroom close solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers ideas in action ask the experts brochures  scientific posters articles  white papers videos recorded webcasts homepage  newsroom patheon nv announces pricing of initial public offering  menu menu solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers ideas in action ask the experts brochures  scientific posters articles  white papers videos recorded webcasts login patheon nv announces pricing of initial public offering category financial wednesday july    pm edt dateline durham nc emailpdfprintrss public company information nysepthn patheon announces price of ipo tweet this durham ncbusiness wirepatheon nv patheon or the company today announced the pricing of the initial public offering of  of its ordinary shares at a public offering price of  per share patheon is selling  ordinary shares and the selling stockholder named in the prospectus is selling  ordinary shares in addition the company has granted the underwriters a day option to purchase up to an additional  ordinary shares from the company the ordinary shares of the company are scheduled to begin trading on the new york stock exchange on july   under the symbol pthn the offering is expected to close on or about july   subject to customary closing conditions the company intends to use the net proceeds it receives from the offering and cash on hand to repay all of its outstanding  million of senior pik toggle notes pay related fees and expenses and accrued interest patheon will not receive any proceeds from the sale of ordinary shares by the selling stockholder j p morgan morgan stanley jefferies and ubs investment bank are acting as lead bookrunning managers and representatives of the underwriters for the offering credit suisse evercore isi and wells fargo securities are acting as joint bookrunning managers for the offering baird piper jaffray raymond james william blair keybanc capital markets and leerink partners are acting as comanagers for the offering the offering will be made only by means of a prospectus the prospectus relating to the offering may be obtained from         j p morgan securities llc morgan stanley  co llc co broadridge financial solutions  varick street second floor  long island avenue new york new york  edgewood new york  attn prospectus department attn prospectus group telephone     jefferies llc ubs securities llc  madison avenue nd floor  avenue of the americas new york new york  new york new york  attn equity syndicate prospectus department attn prospectus department email prospectusdepartmentjefferiescom telephone   telephone     a registration statement relating to these securities has been filed and declared effective with the us securities and exchange commission sec this press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction the statements in this press release that are not historical facts may be forwardlooking statements such forward looking statements based upon the current beliefs and expectations of patheons management are subject to risks and uncertainties which could cause actual results to differ from the forward looking statements accordingly readers should not place undue reliance on forwardlooking statements as a prediction of actual results for more information concerning factors that could cause actual results to differ materially from those conveyed in the forwardlooking statements please refer to the risk factors section of the prospectus included in the registration statement in the form last filed with the sec patheon does not assume any obligation to update the information contained in this press release about patheon nv patheon is a leading global provider of pharmaceutical development and manufacturing services with approximately  employees worldwide patheon provides a comprehensive integrated and highly customizable set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle contact patheon nvfor mediamari mansfield orfor investorspatheon investor relations  newsroom home patheon newsroom company profilefaq leadership news releases videos fact sheet ideas in actionbrochures email alerts media contact mari mansfield emperor blvd durham nc    marimansfieldpatheoncom sign up for email alerts search search this site advanced search     newsroom home patheon newsroom company profilefaq leadership news releases videos fact sheet ideas in actionbrochures email alerts media contact mari mansfield emperor blvd durham nc    marimansfieldpatheoncom sign up for email alerts search search this site advanced search related content patheon overview brochure supply chain management our commitments our leadership solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval  post approval life cycle management about us company profile investor relations our history leadership sites quality our clients our commitments faqs news  press events careers working at patheon job opportunities connect for clients for investors for media members ideas in action ask the experts brochures  scientific posters articles  white papers videos recorded webcasts   patheon® terms of use privacy statement patheonjp business wire newshqsm microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft rp scherer softgel technology  catalent development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us home offerings az offerings rp scherer softgel technologies  share print rp scherer softgel technologies proven innovative versatile as the innovator of softgel technologies catalent rp scherer softgel brings more than  years of development expertise and manufacturing experience to the full spectrum of lipidbased drug delivery softgel technology is proven to enhance bioavailability for poorly soluble molecules it offers numerous advantages that can help bring your challenging compounds to market faster benefit of softgel and lipid based drug delivery system enhance the bioavailability of your poorly watersoluble bcs ii and iv compounds improve dose uniformity of your potent compounds and minimize patienttopatient variability generate faster onset of action reducing api dose minimizing side effects and improving your overall treatment performance reduce development time through a proven dosage form with a strong track record of commercial success get specialized handling and manufacturing for your hormones cytotoxics potent and difficult apis differentiate your brand with various color shape size and printing options and protect your product from counterfeiting and tampering reconsider your product life cycle management by generating a faster onset of action reducing api dose minimizing side effects and improving your overall treatment performance versatile solutionswe enable better outcomes for a broader range of challenging molecules with our deep development expertise advanced delivery technologies and integrated supply solutionsour recent innovations can put even more molecules on a faster path to commercialization optigel™ bio technology for macromolecule encapsulation  optishell® technology for modified release optigel™ lock technology for abuse deterrence optigel™ micro technology for flexible dosing coated softgels suppositories and vaginal ovules how its made catalent rp scherer softgel services preformulation and feasibility studies solubility screening of nces softgel capsule fill formulation development  smallscale lab encapsulation for providing early stability data and final formulation selection shell development an extensive gelatin shell library which enables us to offer a wide variety of gelatin options for a range of products  a large range of shell formula and compatibility possibilities extensive technical support in capsule product development selfemulsifyingmicroemulsion vehicle systems unique formulations leading to potentially patentable line extensions  reliable supply from clinical phases to commercial manufacturing contingency planning and quality assurance via our biggest global network global leader of softgel technologyit is important to work with a high quality reputable industry partner that has the experience and knowledge to help design an optimal softgel formulation based on the specific physicochemical properties of your api  additionally it is advantageous to use the same partner for scaleup and commercial manufacturing with simplified process  as the global leader of softgel technology catalent supported  new drug applications for rx and otc drugs in the last four decades  is the largest softgel manufacturer in the world with  products on the market in  countries salva r and browne j lipidbased drug delivery system to bring poorly soluble drugs to market drug development and delivery september  vol  no  softgel global networkour deep formulation expertise supported by a global infrastructure of cgmp fda ema and locally accredited softgel facilities provide a catalyst to your success by tailoring the drug delivery solutions to bring your product faster to market related topics optishell® technology optigel™ bio technology optigel™ lock technology optigel™ micro technology coated softgels for pharmaceutical drug products thinking trends drug development softgel technology as a tool for bioavailability enhancement seddssmedds compatibility with vegicaps® capsules optishell™ technology capsule innovations contact us contact us resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement catalentunder the lens we produced over b softgels capsules in the year  which is enough for gelatin ribbon to be wrapped  times around the earth see the bigger picture here our locations development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us home about us our locations  share print our locations with our broad range of experience and deep expertise we have the talent and unique technologies to transform your concepts into excellent results this is backed by our global reach with facilities located worldwide enabling us to tailor a solution to fit your needs browse by capability all biologics clinical supply services development  analytical modified release softgel sterile technologies biologics clinical supply services development  analytical modified release softgel sterile technologies view all asia pacific   braeside melbourne au  dee why sydney au  ftz shanghai china  haining china  kakegawa japan  shanghai china  singapore  tokyo japan  europe   aprilia rome italy  bathgate scotland  beinheim france  bolton uk  brussels belgium  cham switzerland  dartford uk  eberbach germany  limoges france  schorndorf germany  swindon uk  latin america   buenos aires argentina  indaiatuba brazil  montevideo uruguay  sorocaba brazil  north america   emeryville ca  kansas city mo  madison wi  malvern pa  morrisvillertp nc  philadelphia pa  san diego ca  somerset nj hq  st petersburg fl  strathroy ontario canada  winchester ky  windsor ontario canada  woodstock il  resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement catalentunder the lens we have proudly built  locations around the globe with a total of over m square feet or enough space to house  boeing s see the bigger picture here contact us development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us home contact us  share print contact us connect with the right expert now catalent offers solutions across your drug development delivery and supply globally  so we need your help to match you with the right experts in the right place tell us your challenge and well get back to you within  hours phone  additional contact options the more we know the faster we can find the best expert for yourequired field name  companyorganisation  phone email  region  please select north america latin america emea china japan australia asia excl chinajapan other what is the purpose of your contact  please select considering solutions for an immediate need evaluating solutions for a project within  months researching solutions for a project greater than  months away no need for a solution just researching the topic provide as much as detail as possible about your challenge  select one primary area of interest  development analytical services cell line development inhalation  respiratory services smartag technology particle size reduction optiform® solution suite optiform® solution suite bio spray dried dispersion delivery softgel rx softgel consumer health hot melt extrusion blow  fill  seal controlled release cosmetics  skin care undecided drug delivery oral fast dissolve zydis supply biologics biomanufacturing clinical supply services comparator sourcing sterile fill  finish regulatory consulting error please see areas highlighted in red submit to see a full list of open positions at catalent and to apply today please click here  to reach the accounts payable department directly please call  to reach the accounts receivable department directly please call   select one primary area of interest  please select analytical services cell line development inhalation  respiratory services smartag technology particle size reduction optiform® solution suite optiform® solution suite bio spray dried dispersion softgel rx softgel consumer health hot melt extrusion blow  fill  seal controlled release cosmetics  skin care undecided drug delivery oral fast dissolve zydis biologics biomanufacturing clinical supply services comparator sourcing sterile fill  finish regulatory consulting error please see areas highlighted in red submit to see a full list of open positions at catalent and to apply today please click here  to reach the accounts payable department directly please call  to reach the accounts receivable department directly please call   connect with the right expert now catalent offers solutions across your drug development delivery and supply globally  so we need your help to match you with the right experts in the right place tell us your challenge and well get back to you within  hours call us us  eurow     corporate services catalent pharma solutions   schoolhouse road somerset nj see all our locations  for general inquiriesclick here  for information on  catalent careersclick here  resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement offerings  catalent development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us overview video offerings with the broadest range of services and technologies to transform your molecule into a successful treatment—from specific challenges tailored solutions or fullyintegrated supportbrowse all offerings broadest offerings deepest expertise whatever your challenge we can help from development to delivery to supply we can improve the total value of your treatmentsplay video  featured offerings development solutions and services as the  global industry partner in drug development we can help you bring more molecules to market faster bioavailability solutions solve solubility and permeability challenges deliver more apis and optimize delivery profiles with our deep expertise and innovative technologies drug delivery technologies from orphan drugs to blockbusters our development expertise delivery technologies and reliable supply deliver better outcomes for payers patients and innovators accelerated development get your drug to market faster with our deep development expertise integrated solutions and flexible scale view offerings by phase whether you are looking for a single tailored solution or multiple answers throughout your products lifecycle we can improve the total value of your treatments  from discovery to market and beyond learn more browse offerings a to z not sure which are right for you try our solutions finder tool browse by tag browse by tag   view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer looking for case studies downloadable brochures and other resources  visit our resource center advasept® lock easily opened and locks to luered syringes for a smooth withdraw advasept® technology advanced aseptic processing providing a glass free solution for parenterals advasept® vial glass free vials as a proven container closure for biologic products animal health our technologies offer dose forms suitable for a variety of species assessment of abusedeterrence specific testing capabilities in the area of abusedeterrent formulations bioavailability solutions our talent and expertise can solve the most complex bioavailability challenges biologics analytical services leading expertise in protein characterization and bioassays biologics overview we can help build you a smooth path from cell line development to product delivery biomanufacturing increase yield and shorten timeline with our expert biomanufacturing capabilities biosimilars optimized and flexible biosimilar programs blowfillseal customized specialty fillfinish solutions that drive the most efficient patient outcomes catalent micron technologies proven and versatile particle size reduction micronization and milling technologies clinical storage and distribution seamless supply chain management cold chain distribution global shipping and tracking clinical supply management expert support throughout the complete clinical supply project clinical supply services integrated pharma resources and project management for your clinical supply chain coated softgels for pharmaceutical drug products improve therapeutic performance and enhance patients experience compendial testing fullservice compendial release testing in stateoftheart facilities consumer health enhance your brand image with consumers preferred delivery systems controlled release complete range of capabilities for tablets  capsules – from development to supply cosmetics and skin care energy beauty and wellbeing all in a capsule cosmopod™ capsules for beauty  plantbased twist off softgel technology for beauty care dry powder inhalants comprehensive services from dosage form and formulation to clinical trial and packaging early stage oral development accelerate development process with reduced risk  improved outcomes easyburst™ chewable capsules convenient to use and can offer higher efficacy than other confectionary forms enhanced therapeutic profiles explore how we can help optimize the therapeutic profiles of your treatments enteric coated softgels for consumer health products improve product performance  enhance consumer experience esolutions webbased fully collaborative platforms for keeping clients informed and updated extractables and leachables identify and quantify levels of extractable and leachable substances in a drug dosage form flexdose℠ ideal packaging solution for a wide range of powder granule liquid and gel formulations flexible manufacturing proven expertise in technology transfers and product launches global comparator sourcing inhouse sourcing specialists plus a global network for access to virtually any product gpex® technology our unique reliable gene retrovector that generates stable mammalian lines in record time hardshell capsules expert development and manufacturing solutions with a competitive edge highly potent active pharmaceutical ingredients integrated development manufacturing and clinical supply solutions inhalant solutionssuspensions expert support from dosage form selection to clinical and commercialscale manufacturing inhalation overview broadest range of services for aseptic processing across all dosage forms integrated supply chain solutions our one central supply chain frees capital ensures highest quality and speeds time to market manufacturing and blinding fullservice vertical integrated operations for clinical trials – phase  to phase iv manufacturing overview over  years of customizing innovative manufacturing and packaging solutions metals testing high quality laboratory based inspection services method development  validation expertly meeting the specificity demands of analytical assays microbiology testing a complete line of services that includes gmpglpanalytical microbiology services nasal sprays comprehensive development support as well as clinical and commercialscale manufacturing offerings by phase browse our integrated services for your products entire lifecycle optiform® api api screening that provides the most stable crystalline form for  compounds optiform® pro web tool enables professionals to determine the optimal finished dose for your product optiform® select formulation screening fast solubility for preclinical efficacy testing and lead selection optiform® solution suite designed to accelerate more molecules to clinic and beyond optiform® solution suite bio fast macromolecule screening for oral delivery optigel™ bio technology enabling iv to oral conversion of macromolecules optigel™ lock technology enabling abuse deterrence in rp scherer softgel optigel™ micro technology a smaller easy to swallow softgel with the added benefit of dose titration optigel™ mini technology innovative oral softgel platform that delivers full strength apis in a small powerful softgel optimelt® hot melt extrusion optimelt® hot melt extrusion can enhance bioavailability of your poorly soluble api optipact™ technology fast and scalable process for your orphan and accelerated drug development success optishell® technology expanding the range of fill formulations into softgels packaging and labeling advanced technologies and custom solutions to advance your timelines and enhance branding pharmatek™ sd spray drying technology enhance bioavailability of your poorly soluble api prefilled syringes the latest in fillfinish process advanced needle safety and specialty autodevices regulatory consulting proven comprehensive services from regulatory training to global submissions guidance savorgel™ technology easy to administer offers higher compliance and is enjoyable for animals softdrop™ oral technology innovative oral delivery platform capable of delivering multiple actives softgel technology as innovators of softgel technology we offer integrated services across the entire lifecyle stability testing standardcustom preclinical and clinical testing services – placebos to controlled drugs sterile fillfinish expertise from process design to regulatory support for virtually any sterile dosage form structure characterization our expertise encompasses the full range of large and small molecules tablets customized oral solids development and manufacturing to your most stringent requirements vegicaps® capsules our proprietary plantderived shell for semisolid compounds by the softgel innovators zydis® fastdissolve technology our unique solid oral dosage that dissolves instantly in mouth enhancing absorption resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement news  events  catalent development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us news  eventsour newest offerings and capabilities recent investments in technologies expertise and capacity upcoming conferences and events catalent news events catalent news july   catalent applied drug delivery institute appoints jim spavins to advisory board july  july   catalent applied drug delivery institute partners with rutgers university july  july   catalent launches new optiform® solution suite july  july   pfizer partners with catalent for the manufacture of advil® liquigels® minis july  july   catalent to host industry experts at controlled release society conference july  june   advancements in biologics and fasttrack development of low solubility compounds june  may   catalent to host spray drying technology symposium may  may   catalent biologics announces collaboration with therachon switzerland may  may   catalent to showcase expanded formulation toolkit and innovative technologies may  view all news view all catalent news events august   buenos aires argentina expofybi  august  buenos aires argentina september   singapore asia vitafoods asia september  singapore asia september   philadelphia pa controlled  modified drug release september  philadelphia pa september   new brunswick nj contract pharma september  new brunswick nj september   san diego ca world adc conference september  san diego ca september   tbd boulder peptide symposium september  tbd september   boston ma bpi east september  boston ma september   las vegas nv supplyside west september  las vegas nv october   tokyo japan health ingredients japan october  tokyo japan view all events view complete event listing resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement patheon  global pharma contract development  manufacturing cdmo  a healthier world delivered play video careers investors connect solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers connect ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts close solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers connect ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts menu menu solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers connect ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts flexible biomanufacturing reduce your risks instead of your return learn more about our flexible biomanufacturing capabilities news  june  patheon to invest  million expanding capabilities to support continued growt connect connect with patheon today biomanufacturing for consultants reduce your clients’ risks instead of their return checkout our consultants’ guide to flexible biomanufacturing solutions event  august    august  the summer symposium on process chemistry news  june  patheon reports fiscal  second quarter flexible manufacturing customized solutions adaptable capacity welcome to truly flexible drug manufacturing events  august    august  the bioprocesssing summit company profile discover how patheon has the innovation and expertise to transform the pharma industry ask the experts  our scientific experts are here to answer your inquiries submit your question here events  august    august  american drug delivery  formulation summit news  may  thermo fisher scientific to acquire patheon a leading contract development and  formulation learn more about the solid and sterile dose forms available at patheon solubility solutions welcome to getting solubility right the first time see our solubility enhancement solutions linkedin social media twitter patheon onesource see how patheon onesource™ accelerates every step of drug development  and more importantly eliminates the spaces between them patheon at a glance download our company overview pdf looking for solutions we can help connect with us solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval  post approval life cycle management about us company profile investor relations our history leadership sites quality our clients our commitments faqs news  press events careers working at patheon job opportunities connect for clients for investors for media members for job seekers ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts   patheon®terms of use privacy statement patheonjp patheon  wikipedia patheon from wikipedia the free encyclopedia jump to navigation search patheon nv type public company traded as nyse pthn industry contract pharmaceutical services headquarters amsterdam the netherlands key people james c mullen ceo stuart grant cfo and executive vp revenue  billion  number of employees  website wwwpatheoncom patheon nv is a pharmaceutical contract development and manufacturing organization cdmo headquartered in amsterdam it provides contract development and manufacturing services of prescription and overthecounter pharmaceutical products for approximately  pharmaceutical and biotechnology companies it was founded in  as custom pharmaceuticals ltd and changed its name to patheon in  when it was first publicly traded the new york private equity firm jll partners has owned a controlling stake in patheon since  in  patheon merged with the drug manufacturing business of royal dsm nv becoming a jointventure between jll partners and dsm as of  patheon owns manufacturing sites in north america europe japan australia and canada contents  history  dosage forms products  references  external links historyedit patheon was founded in canada in  as custom pharmaceuticals ltd in  it began to expand to us markets custom pharmaceuticals changed its name to patheon in  and was first publicly traded that year on the toronto stock exchange in  patheon acquired mova a drug manufacturer based in puerto rico us the deal proved unprofitable and in  the new york equity firm jll partners provided patheon  million to restructure two years later after a failed takeover bid by lonza group jll partners bought a controlling interest in the company in  patheon acquired banner pharmacaps a drug manufacturer specializing in softgels for  million patheon changed the companys name the following year to banner life sciences in a  billion deal patheon merged with the pharmaceutical division of royal dsm nv in  after jll partners bought a controlling stake in the latter as well adding significantly to patheons european production capacity in  patheon acquired agere pharmaceuticals an oregon us company specializing in drug solubility and irix a maker of specialist active pharmaceutical ingredients in south carolina us the latter for  million in may  thermo fisher scientific announced it would acquire patheon for  billion dosage forms productsedit patheon does not own any of the licences of the products it manufactures and is often listed as the manufacturer on packaging with the product licence holders brand name product name and corporate identity being used patheons clients include such pharmaceutical brands as merck  co novartis and sanofi aventis with biotechnology customers including amgen and avanir pharmaceuticals patheon has manufactured or developed more than  products development activities are undertaken by patheon pharmaceutical development services known as pds a division of patheon inc operating in europe canada and the united states as of  patheon owns manufacturing sites in canada the continental us puerto rico france the united kingdom italy austria germany the netherlands japan and australia patheon manufactures products in various dosage forms oral tablets capsules injectable sterile products vials ampoules prefilled syringes containing liquids powders and lyophilisates and topicals creams ointments drops nasal sprays medicated and nonmedicated gauze referencesedit  leadership patheoncom patheon retrieved may     palmer eric june   updated patheon revenues hit b in first year as part of dpx fiercepharmacom fierce pharma retrieved may     a b company profile patheoncom patheon retrieved may     a b history and milestones patheoncom patheon retrieved may     erman boyd july   long takeover battle a bitter pill for patheon theglobeandmailcom the globe and mail retrieved may     xu jodi november   jll forms new pharma firm with dsm in  billion deal bloombergcom bloomberg retrieved may     a b sites patheoncom patheon retrieved may      takeover failures revisited   httpwwwbizjournalscomtriadblogpatheonchangingbannerpharmacapsnamehtml  jll forms new pharma firm with dsm in  billion deal  november  – via wwwbloombergcom   biopharmareportercom patheon propels itself into us biologics market in gallus acquisition   trlpcpatheon to raise  mln euro loan for irix acquisition  march  – via reuters   httpwwwbizjournalscomportlandmorningcalloregonpharmacompanysoldtonorthcarolinahtml  thermo fisher scientific to acquire patheon for b  gen genetic engineering  biotechnology news  biotech from bench to business  gen gen   patheon by the numbers pdf patheoncom patheon retrieved may    external linksedit patheon home page retrieved from httpsenwikipediaorgwindexphptitlepatheonoldid categories companies established in pharmaceutical companies of the netherlandscompanies based in amsterdamcompanies listed on the new york stock exchange initial public offeringshidden categories pages using deprecated image syntax navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view creative commons — attributionsharealike  unported — cc bysa  skip to content menu help us build a vibrant collaborative global commons donate now creative commons creative commons license deed attributionsharealike  unported cc bysa  this is a humanreadable summary of and not a substitute for the license disclaimer you are free to share — copy and redistribute the material in any medium or format adapt — remix transform and build upon the material for any purpose even commercially the licensor cannot revoke these freedoms as long as you follow the license terms under the following terms attribution — you must give appropriate credit provide a link to the license and indicate if changes were made you may do so in any reasonable manner but not in any way that suggests the licensor endorses you or your use attribute this work sharealike — if you remix transform or build upon the material you must distribute your contributions under the same license as the original no additional restrictions — you may not apply legal terms or technological measures that legally restrict others from doing anything the license permits notices you do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation no warranties are given the license may not give you all of the permissions necessary for your intended use for example other rights such as publicity privacy or moral rights may limit how you use the material learn more about cc licensing or use the license for your own material this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work make a donation this page is available in the following languages castellano castellano españa català dansk deutsch english esperanto français galego hrvatski indonesia italiano latviski lietuvių melayu nederlands norsk polski português português br română slovenščina suomeksi svenska türkçe íslenska česky ελληνικά беларуская русский українська العربية پارسی     한국어 this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work when you share everyone wins contribute today to creative commons     disclaimer this deed highlights only some of the key features and terms of the actual license it is not a license and has no legal value you should carefully review all of the terms and conditions of the actual license before using the licensed material creative commons is not a law firm and does not provide legal services distributing displaying or linking to this deed or the license that it summarizes does not create a lawyerclient or any other relationship what does attribute this work mean the page you came from contained embedded licensing metadata including how the creator wishes to be attributed for reuse you can use the html here to cite the work doing so will also include metadata on your page so that others can find the original work as well the applicable mediation rules will be designated in the copyright notice published with the work or if none then in the request for mediation unless otherwise designated in a copyright notice attached to the work the uncitral arbitration rules apply to any arbitration more info if supplied you must provide the name of the creator and attribution parties a copyright notice a license notice a disclaimer notice and a link to the material cc licenses prior to version  also require you to provide the title of the material if supplied and may have other slight differences more info in  you must indicate if you modified the material and retain an indication of previous modifications in  and earlier license versions the indication of changes is only required if you create a derivative marking guide more info you may also use a license listed as compatible at httpscreativecommonsorgcompatiblelicenses more info a commercial use is one primarily intended for commercial advantage or monetary compensation more info merely changing the format never creates a derivative more info the license prohibits application of effective technological measures defined with reference to article  of the wipo copyright treaty more info the rights of users under exceptions and limitations such as fair use and fair dealing are not affected by the cc licenses more info you may need to get additional permissions before using the material as you intend more info patheon  global pharma contract development  manufacturing cdmo  a healthier world delivered play video careers investors connect solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers connect ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts close solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers connect ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts menu menu solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news  press events investor relations careers connect ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts flexible biomanufacturing reduce your risks instead of your return learn more about our flexible biomanufacturing capabilities news  june  patheon to invest  million expanding capabilities to support continued growt connect connect with patheon today biomanufacturing for consultants reduce your clients’ risks instead of their return checkout our consultants’ guide to flexible biomanufacturing solutions event  august    august  the summer symposium on process chemistry news  june  patheon reports fiscal  second quarter flexible manufacturing customized solutions adaptable capacity welcome to truly flexible drug manufacturing events  august    august  the bioprocesssing summit company profile discover how patheon has the innovation and expertise to transform the pharma industry ask the experts  our scientific experts are here to answer your inquiries submit your question here events  august    august  american drug delivery  formulation summit news  may  thermo fisher scientific to acquire patheon a leading contract development and  formulation learn more about the solid and sterile dose forms available at patheon solubility solutions welcome to getting solubility right the first time see our solubility enhancement solutions linkedin social media twitter patheon onesource see how patheon onesource™ accelerates every step of drug development  and more importantly eliminates the spaces between them patheon at a glance download our company overview pdf looking for solutions we can help connect with us solutions  services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval  post approval life cycle management about us company profile investor relations our history leadership sites quality our clients our commitments faqs news  press events careers working at patheon job opportunities connect for clients for investors for media members for job seekers ideas in action ask the experts brochures  scientific posters articles  white papers corporate videos recorded webcasts   patheon®terms of use privacy statement patheonjp patheon  wikipedia patheon from wikipedia the free encyclopedia jump to navigation search patheon nv type public company traded as nyse pthn industry contract pharmaceutical services headquarters amsterdam the netherlands key people james c mullen ceo stuart grant cfo and executive vp revenue  billion  number of employees  website wwwpatheoncom patheon nv is a pharmaceutical contract development and manufacturing organization cdmo headquartered in amsterdam it provides contract development and manufacturing services of prescription and overthecounter pharmaceutical products for approximately  pharmaceutical and biotechnology companies it was founded in  as custom pharmaceuticals ltd and changed its name to patheon in  when it was first publicly traded the new york private equity firm jll partners has owned a controlling stake in patheon since  in  patheon merged with the drug manufacturing business of royal dsm nv becoming a jointventure between jll partners and dsm as of  patheon owns manufacturing sites in north america europe japan australia and canada contents  history  dosage forms products  references  external links historyedit patheon was founded in canada in  as custom pharmaceuticals ltd in  it began to expand to us markets custom pharmaceuticals changed its name to patheon in  and was first publicly traded that year on the toronto stock exchange in  patheon acquired mova a drug manufacturer based in puerto rico us the deal proved unprofitable and in  the new york equity firm jll partners provided patheon  million to restructure two years later after a failed takeover bid by lonza group jll partners bought a controlling interest in the company in  patheon acquired banner pharmacaps a drug manufacturer specializing in softgels for  million patheon changed the companys name the following year to banner life sciences in a  billion deal patheon merged with the pharmaceutical division of royal dsm nv in  after jll partners bought a controlling stake in the latter as well adding significantly to patheons european production capacity in  patheon acquired agere pharmaceuticals an oregon us company specializing in drug solubility and irix a maker of specialist active pharmaceutical ingredients in south carolina us the latter for  million in may  thermo fisher scientific announced it would acquire patheon for  billion dosage forms productsedit patheon does not own any of the licences of the products it manufactures and is often listed as the manufacturer on packaging with the product licence holders brand name product name and corporate identity being used patheons clients include such pharmaceutical brands as merck  co novartis and sanofi aventis with biotechnology customers including amgen and avanir pharmaceuticals patheon has manufactured or developed more than  products development activities are undertaken by patheon pharmaceutical development services known as pds a division of patheon inc operating in europe canada and the united states as of  patheon owns manufacturing sites in canada the continental us puerto rico france the united kingdom italy austria germany the netherlands japan and australia patheon manufactures products in various dosage forms oral tablets capsules injectable sterile products vials ampoules prefilled syringes containing liquids powders and lyophilisates and topicals creams ointments drops nasal sprays medicated and nonmedicated gauze referencesedit  leadership patheoncom patheon retrieved may     palmer eric june   updated patheon revenues hit b in first year as part of dpx fiercepharmacom fierce pharma retrieved may     a b company profile patheoncom patheon retrieved may     a b history and milestones patheoncom patheon retrieved may     erman boyd july   long takeover battle a bitter pill for patheon theglobeandmailcom the globe and mail retrieved may     xu jodi november   jll forms new pharma firm with dsm in  billion deal bloombergcom bloomberg retrieved may     a b sites patheoncom patheon retrieved may      takeover failures revisited   httpwwwbizjournalscomtriadblogpatheonchangingbannerpharmacapsnamehtml  jll forms new pharma firm with dsm in  billion deal  november  – via wwwbloombergcom   biopharmareportercom patheon propels itself into us biologics market in gallus acquisition   trlpcpatheon to raise  mln euro loan for irix acquisition  march  – via reuters   httpwwwbizjournalscomportlandmorningcalloregonpharmacompanysoldtonorthcarolinahtml  thermo fisher scientific to acquire patheon for b  gen genetic engineering  biotechnology news  biotech from bench to business  gen gen   patheon by the numbers pdf patheoncom patheon retrieved may    external linksedit patheon home page retrieved from httpsenwikipediaorgwindexphptitlepatheonoldid categories companies established in pharmaceutical companies of the netherlandscompanies based in amsterdamcompanies listed on the new york stock exchange initial public offeringshidden categories pages using deprecated image syntax navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view patheon patheon  twitter skip to content home home home current page moments moments moments current page search query search twitter saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  language english bahasa indonesia bahasa melayu català čeština dansk deutsch english uk español filipino français hrvatski italiano magyar nederlands norsk polski português română slovenčina suomi svenska tiếng việt türkçe ελληνικά български език русский српски українська мова עִבְרִית العربية فارسی मराठी हिन्दी বাংলা ગુજરાતી தமிழ் ಕನ್ನಡ ภาษาไทย 한국어  简体 繁體 have an account log in have an account remember me · forgot password new to twitter sign up patheonverified account patheon tweets tweets current page  following following  followers followers  likes likes    more likes unmute patheon mute patheon follow following unfollow blocked unblock pending cancel patheonverified account patheon patheon is a leading global cdmo and provider of outsourced pharmaceutical development and manufacturing services ahealthierworld worldwide patheoncom joined april   photos and videos photos and videos tweets tweets tweets current page tweets  replies media you blocked patheon are you sure you want to view these tweets viewing tweets wont unblock patheon yes view profile close patheon followed patheon‏verified account patheon h hours ago more copy link to tweet embed tweet parrish galliher cto at upstream of ge healthcare life sciences with industry manufacturing recommendationshttpowlylnedlz   replies  retweet  like reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet from outsourcedpharm – patheons franco negron explains the pharma industrys need for more products details httpowlyyihqdkl pictwittercomfycgqmnfbx  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon retweeted the medicine maker‏ medicinemaker jul  more copy link to tweet embed tweet charlotte barker speaks with lukas utiger from patheon httpowlyzajvdrai pictwittercomsadlmeef  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet our goal is ahealthierworld for all – to enjoy both the big events and the little moments in lifepictwittercomlirjppyj  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo patheon retweeted the medicine maker‏ medicinemaker jul  more copy link to tweet embed tweet steve lam shares his lessons learned over  decades in pharma patheon httpowlyrdgrts pictwittercomazeqlhksh  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet another great scalable pharmaceuticaldevelopment event at viognier restaurant in san francisco viognierchef pharmadevelopmentpictwittercombzwignw  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet patheons john burke discusses  steps of the lyophilization cycle as well as benefits  pitfalls to avoid httpowlywqjvdzqk pictwittercommlkxmur  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet todays the last day of the crs annual meeting due to the workshops  presentations were walking away with valuable drug delivery info  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet here are jon sutch and sanjay konagurthu patheon execs expanding on our spraydrying technologyhttpowlygsbdyrr   replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet quality assurance checks ensure that we deliver ahealthierworld faster stronger and betterpictwittercomoydgmjoe  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet should you stay inhouse or outsource during biologic drug development read our new whitepaper to find out httpowlyeaddbkw pictwittercomggvhbqp  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet did you miss our recent complexmolecule webcast you can watch it ondemand via manchempharma here httpowlysftcdbja pictwittercomeovicun  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon retweeted the medicine maker‏ medicinemaker jul  more copy link to tweet embed tweet steve lam shares his lessons learned over  decades in pharma patheon httpowlyziidaqmn pictwittercomcpfcapzr  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet patheon enters manufacturing agreement with caelumbio for phase  studies in amyloidosis httpowlyidxrdyt pictwittercomfdvzfkhj  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet flexible manufacturing can help the pharma industry avoid high costs of inaccurate demand forecasts learn more httpowlyxopdxou pictwittercomlwkbijtyd  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet join patheons anil kane as he moderates a pharma lifecycle management roundtable at crsboston on  learn more httpowlygtlfdbjcb pictwittercomlbdviwqrs  replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo patheon retweeted dr kyle dsilva‏ pharmaanalysis jul  more copy link to tweet embed tweet cdmo rise due to large pharma capacity constraints  access to new technology  pharmareview patheonhttpowlyetxudttsc   replies  retweet  like reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet great article on the history  future of pharma contract manufacturing from pharmtechgroup  httpowlymcredzvnv   reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon‏verified account patheon jul  more copy link to tweet embed tweet kaspar van den dries patheon exec on the problem of poor bioavailability  lipid formulation herehttpowlynhxodwwt   replies  retweet  like reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon retweeted simon bubnic‏ sbubnic jul  more copy link to tweet embed tweet top  risks facing small biopharma clients patheon bioprocessolhttpslnkdinegtstt   replies  retweet  like reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo patheon hasnt tweeted yet back to top ↑ loading seems to be taking a while twitter may be over capacity or experiencing a momentary hiccup try again or visit twitter status for more information new to twitter sign up now to get your own personalized timeline sign up you may also like · refresh false   twitter about help center terms privacy policy cookies ads info close choose a trend location dismiss close previous next close go to a persons profile saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  close promote this tweet close block cancel block add a location to your tweets when you tweet with a location twitter stores that location you can switch location onoff before each tweet and always have the option to delete your location history learn more turn location on not now close share location results from send close your lists close create a new list list name description under  characters optional privacy public · anyone can follow this list private · only you can access this list save list close close copy link to tweet heres the url for this tweet copy it to easily share with friends close embed this tweet embed this video add this tweet to your website by copying the code below learn more add this video to your website by copying the code below learn more hmm there was a problem reaching the server try again include parent tweet include media by embedding twitter content in your website or app you are agreeing to the twitter developer agreement and developer policy preview close why youre seeing this ad close log in to twitter remember me · forgot password dont have an account sign up » close sign up for twitter not on twitter sign up tune into the things you care about and get updates as they happen sign up have an account log in » close twoway sending and receiving short codes country code for customers of united states  any canada  any united kingdom  vodafone orange  o brazil  nextel tim haiti  digicel voila ireland  vodafone o india  bharti airtel videocon reliance indonesia  axis  telkomsel indosat xl axiata italy  wind  vodafone » see sms short codes for other countries close confirmation close   close skip all welcome home this timeline is where you’ll spend most of your time getting instant updates about what matters to you tweets not working for you hover over the profile pic and click the following button to unfollow any account say a lot with a little when you see a tweet you love tap the heart — it lets the person who wrote it know you shared the love spread the word the fastest way to share someone else’s tweet with your followers is with a retweet tap the icon to send it instantly join the conversation add your thoughts about any tweet with a reply find a topic you’re passionate about and jump right in learn the latest get instant insight into what people are talking about now get more of what you love follow more accounts to get instant updates about topics you care about find whats happening see the latest conversations about any topic instantly never miss a moment catch up instantly on the best stories happening as they unfold back next next tweet from user patheon  wikipedia patheon from wikipedia the free encyclopedia jump to navigation search patheon nv type public company traded as nyse pthn industry contract pharmaceutical services headquarters amsterdam the netherlands key people james c mullen ceo stuart grant cfo and executive vp revenue  billion  number of employees  website wwwpatheoncom patheon nv is a pharmaceutical contract development and manufacturing organization cdmo headquartered in amsterdam it provides contract development and manufacturing services of prescription and overthecounter pharmaceutical products for approximately  pharmaceutical and biotechnology companies it was founded in  as custom pharmaceuticals ltd and changed its name to patheon in  when it was first publicly traded the new york private equity firm jll partners has owned a controlling stake in patheon since  in  patheon merged with the drug manufacturing business of royal dsm nv becoming a jointventure between jll partners and dsm as of  patheon owns manufacturing sites in north america europe japan australia and canada contents  history  dosage forms products  references  external links historyedit patheon was founded in canada in  as custom pharmaceuticals ltd in  it began to expand to us markets custom pharmaceuticals changed its name to patheon in  and was first publicly traded that year on the toronto stock exchange in  patheon acquired mova a drug manufacturer based in puerto rico us the deal proved unprofitable and in  the new york equity firm jll partners provided patheon  million to restructure two years later after a failed takeover bid by lonza group jll partners bought a controlling interest in the company in  patheon acquired banner pharmacaps a drug manufacturer specializing in softgels for  million patheon changed the companys name the following year to banner life sciences in a  billion deal patheon merged with the pharmaceutical division of royal dsm nv in  after jll partners bought a controlling stake in the latter as well adding significantly to patheons european production capacity in  patheon acquired agere pharmaceuticals an oregon us company specializing in drug solubility and irix a maker of specialist active pharmaceutical ingredients in south carolina us the latter for  million in may  thermo fisher scientific announced it would acquire patheon for  billion dosage forms productsedit patheon does not own any of the licences of the products it manufactures and is often listed as the manufacturer on packaging with the product licence holders brand name product name and corporate identity being used patheons clients include such pharmaceutical brands as merck  co novartis and sanofi aventis with biotechnology customers including amgen and avanir pharmaceuticals patheon has manufactured or developed more than  products development activities are undertaken by patheon pharmaceutical development services known as pds a division of patheon inc operating in europe canada and the united states as of  patheon owns manufacturing sites in canada the continental us puerto rico france the united kingdom italy austria germany the netherlands japan and australia patheon manufactures products in various dosage forms oral tablets capsules injectable sterile products vials ampoules prefilled syringes containing liquids powders and lyophilisates and topicals creams ointments drops nasal sprays medicated and nonmedicated gauze referencesedit  leadership patheoncom patheon retrieved may     palmer eric june   updated patheon revenues hit b in first year as part of dpx fiercepharmacom fierce pharma retrieved may     a b company profile patheoncom patheon retrieved may     a b history and milestones patheoncom patheon retrieved may     erman boyd july   long takeover battle a bitter pill for patheon theglobeandmailcom the globe and mail retrieved may     xu jodi november   jll forms new pharma firm with dsm in  billion deal bloombergcom bloomberg retrieved may     a b sites patheoncom patheon retrieved may      takeover failures revisited   httpwwwbizjournalscomtriadblogpatheonchangingbannerpharmacapsnamehtml  jll forms new pharma firm with dsm in  billion deal  november  – via wwwbloombergcom   biopharmareportercom patheon propels itself into us biologics market in gallus acquisition   trlpcpatheon to raise  mln euro loan for irix acquisition  march  – via reuters   httpwwwbizjournalscomportlandmorningcalloregonpharmacompanysoldtonorthcarolinahtml  thermo fisher scientific to acquire patheon for b  gen genetic engineering  biotechnology news  biotech from bench to business  gen gen   patheon by the numbers pdf patheoncom patheon retrieved may    external linksedit patheon home page retrieved from httpsenwikipediaorgwindexphptitlepatheonoldid categories companies established in pharmaceutical companies of the netherlandscompanies based in amsterdamcompanies listed on the new york stock exchange initial public offeringshidden categories pages using deprecated image syntax navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view